
Infinity Pharmaceuticals INFI
Quartalsbericht 2023-Q2
hinzugefügt 10.08.2023
Infinity Pharmaceuticals DPO 2011-2026 | INFI
DPO Jährlich Infinity Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1.05 K | 81 | 6.33 K | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.33 K | 81 | 2.49 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.88 | - | $ 6.47 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 22.56 | -0.49 % | $ 3.74 B | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.1 | 0.12 % | $ 438 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 23.01 | -1.2 % | $ 2.93 B | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.43 | -3.38 % | $ 381 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Evogene Ltd.
EVGN
|
62.6 | $ 0.8 | 1.25 % | $ 27.9 M | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
CASI Pharmaceuticals
CASI
|
123 | - | - | $ 35.4 M | ||
|
BioXcel Therapeutics
BTAI
|
34.2 K | $ 1.04 | -1.56 % | $ 12.7 M |